Try our Advanced Search for more refined results

Expert Analysis

How Fed. Circ. Is Applying Section 101 To Drug Patents

By Mark Waddell, Ryan Hagglund and Dan Liu ( May 12, 2023, 6:25 PM EDT) -- Between 2010 and 2014, the U.S. Supreme Court issued four decisions on patent subject matter eligibility under Title 35 of the U.S. Code, Section 101 —  Bilski v. Kappos,[1] Mayo Collaborative Services v. Prometheus Labs Inc.,[2] Association for Molecular Pathology v. Myriad Genetics Inc.[3] and Alice Corp v. CLS Bank International[4] — establishing its modern Section 101 jurisprudence....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!